VersaViewer
by GE Medical Systems SCS
· Based in United States →
— Intelligent Medical Image Processing and Analysis for Diagnosis
Not available publicly
Regulatory Status Disclosed
Overview
VersaViewer is a medical diagnosis software developed by GE Medical Systems SCS, designed for the comprehensive processing and analysis of 2D, 3D, and 4D medical images. It supports various imaging modalities, providing radiologists and clinicians with a flexible display framework and a suite of tools to facilitate multimodality imaging review and analysis. The software offers robust measurement, annotation, and segmentation capabilities, along with advanced visualization options to assist trained healthcare professionals in their diagnostic workflows.
A key feature of VersaViewer is its optional One View component, which leverages AI-based deep learning for automated multi-organ segmentation. This functionality aims to enhance radiologists’ efficiency, particularly in interpreting complex spectral CT exams. VersaViewer is intended to assist physicians in diagnosis, with the understanding that the physician retains final responsibility for all patient management decisions.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- 2D, 3D, and 4D medical image processing and display
- Multi-modality image support
- Customizable layouts for multimodality review
- Measurement tools
- Annotation tools
- Segmentation tools
- Advanced visualization options
- Optional One View feature with AI-based deep learning for multi-organ segmentation
- DICOM support for image and findings export
- Assists in interpreting spectral CT exams
Use Cases
- Medical diagnosis assistance for trained healthcare professionals
- Multimodality imaging review and analysis
- Streamlining standard and advanced medical imaging analysis
- Enhancing efficiency in interpreting spectral CT exams
- Processing and analysis of various medical imaging data
What Physicians Need to Know
Evidence Base
VersaViewer's development includes design control testing according to GE HealthCare's quality system, encompassing verification, validation, software lifecycle assessment, and safety testing. Bench testing was performed for its deep learning segmentation algorithm using a representative retrospective CT exam database.
Clinical Validation Studies
The software underwent design control testing, verification, and validation, with bench testing specifically conducted for its deep learning segmentation algorithm, meeting acceptance criteria. Overall testing confirmed substantial equivalence with predicate devices.
Differential Diagnosis Support
VersaViewer assists physicians in diagnosis by providing a display framework and tools for multimodality imaging review and analysis. It offers measurement, annotation, segmentation tools, and advanced visualization options, including an optional AI-based 'One View' feature for automated multi-organ segmentation, which enhances efficiency in interpreting spectral CT exams.
Clinical Workflow Integration
The software is designed to streamline radiological workflows by processing and analyzing 2D, 3D, and 4D medical images from multiple modalities. It provides customizable layouts for multimodality review and outputs images and findings with DICOM support. The 'One View' feature unifies multi-energy datasets into a single, AI-optimized view, reducing cognitive load and aiding uninterrupted decision-making for radiologists.
Decision Audit Trail
GE HealthCare's advanced visualization applications, which include VersaViewer, adhere to DICOM Conformance Statements that detail Audit Trail Messages. The company generally emphasizes immutable audit trails for its AI solutions, recording system actions, queries, or decisions in tamper-resistant logs to support accountability.
Physician Tip
Leverage VersaViewer's advanced visualization and AI-powered segmentation tools, particularly the 'One View' feature for spectral CT, to enhance efficiency and confidence in image interpretation. While the tool assists in diagnosis, remember that final clinical decisions remain the physician's responsibility. Utilize its comprehensive measurement and annotation capabilities for thorough analysis and documentation.
VersaViewer supports DICOM for seamless integration into existing radiological workflows and image management systems. It is designed to work within a multimodality imaging environment, providing a unified display framework for various medical image series.
Details
| Category | Clinical Decision Support & Reference, Radiology & Imaging AI |
| Pricing | Not available publicly |
| Deployment | Software application (likely workstation/server-based) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated VersaViewer is a medical diagnosis software cleared by the FDA under K243651 on April 21, 2025, for processing and analyzing 2D, 3D, and 4D medical images from multiple modalities to assist trained healthcare professionals in diagnostic workflows. It includes an optional One View feature with AI-based deep learning for automated multi-organ segmentation. |
| Integrations | |
| EHR | Not specified |
| Specialties | Nuclear Medicine, Radiology |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate VersaViewer
Press & Coverage
GE HealthCare
News Brief: Computed Tomography | GE HealthCare (United States)
GE HealthCare announced new applications on its AW ONE platform, including VersaVieweru2122 with One View, which simplifies Spectral CT interpretation by unifying multi-energy datasets into a single, AI-optimized view. This aims to reduce cognitive load and help radiologists focus on confident decision-making.
2025-12
Recyclemedica.com
GE Healthcare Unleashes a Wave of New Products: MRI, PCCT, and AI Imaging Upgraded Across the Board! - Recyclemedica.com
At RSNA 2025, GE HealthCare showcased updates to its AW One visualization platform, including VersaViewer with One View for easier spectral CT reading. VersaViewer is described as a software application for processing and analysis of 2D, 3D, and 4D medical imaging data.
2025-12
RadAI Slice
VersaViewer | FDA Radiology AI Device - X-ray Interpreter
VersaViewer, developed by GE Medical Systems SCS, is a medical image management and processing system software that received FDA approval on April 21, 2025. It supports 2D, 3D, and 4D medical images and includes an optional One View feature with AI-based deep learning for automated multi-organ segmentation.
2025-04
FDA
April 21, 2025 GE Medical Systems SCS Peter Uhlir Regulatory Affairs Program Manager 283, rue de la Miniere BUC, 78530 FRANC - accessdata.fda.gov
This FDA document details the substantial equivalence determination for VersaViewer, a medical diagnosis software from GE Medical Systems SCS, approved on April 21, 2025. It highlights that VersaViewer successfully completed design control testing and complies with DICOM standards.
2025-04
AuntMinnie
GE HealthCare features new MRI scanners, PCCT system - AuntMinnie
At RSNA 2025, GE HealthCare showcased an upgrade to its advanced visualization platform, AW One, which now incorporates VersaViewer with One View to simplify spectral CT interpretation. This enhancement is part of GEHC's efforts to advance imaging technology.
2025-12
FDA
K243651 - 510(k) Premarket Notification - FDA
This FDA 510(k) Premarket Notification confirms the classification of VersaViewer as a radiological image processing system, with a decision date of April 21, 2025, indicating it was found Substantially Equivalent (SESE).
2025-04
Innolitics
View (K253639) u2014 FDA 510(k) | Innolitics
Innolitics lists VersaViewer (K243651) as a GE Medical Systems SCS product, classified as a radiological image processing system, with its FDA 510(k) clearance in 2025.
2026-01
GE HealthCare
Advanced Visualization Applications DICOM CONFORMANCE STATEMENT - GE Healthcare
This DICOM Conformance Statement from GE HealthCare, updated in 2025, includes VersaViewer (Release 1.0.0 and higher) among its advanced visualization applications. It details the application's capabilities to interact with DICOM services for retrieving, displaying, processing, and archiving medical images.
2025-01
Videos
Product demos, reviews, and walkthroughs for VersaViewer.
Loading videos...
Frequently Asked Questions
VersaViewer is designed for seamless integration with most Electronic Health Record (EHR) systems, allowing physicians to access AI-powered insights directly within their current interface. It primarily analyzes de-identified patient data, such as imaging, lab results, and clinical notes, to provide decision support and streamline tasks like documentation and coding.
Yes, VersaViewer is built with robust security measures to ensure full compliance with HIPAA, GDPR, and other relevant data privacy regulations, utilizing encryption and strict access controls. Depending on its specific functionalities, it holds appropriate regulatory clearances (e.g., FDA 510(k) or CE Mark) as a medical device, which is crucial for AI tools that impact direct patient care.
VersaViewer employs advanced encryption protocols for data in transit and at rest, along with strict access controls and audit trails to protect patient information. All data processing adheres to de-identification best practices and complies with HIPAA's Privacy and Security Rules to minimize privacy risks while maximizing utility.
VersaViewer differentiates itself through its intuitive user interface, specialized algorithms tailored for specific medical disciplines, and a proven track record of improving diagnostic accuracy and efficiency. Its comprehensive integration capabilities and focus on augmenting, rather than replacing, human intelligence also set it apart from more siloed solutions.
VersaViewer typically offers a tiered subscription model based on factors like the number of users, features required, or data volume processed, with options for annual or multi-year contracts. Custom enterprise solutions and pilot programs are also available, often incorporating hybrid models that combine a base fee with variable components for flexibility.
While highly accurate, VersaViewer's AI is a decision support tool and does not replace clinical judgment; it may have limitations in rare or atypical cases not represented in its training data. Ethical considerations include ensuring transparency in AI outputs, mitigating potential biases in algorithms, and maintaining physician oversight in all diagnostic and treatment decisions to prevent dehumanization of care.
VersaViewer offers comprehensive onboarding, ongoing technical support, and regular training sessions for physicians and clinical staff to ensure optimal utilization. Resources include online tutorials, user manuals, and dedicated support specialists, addressing concerns about unfamiliarity and integration into daily routines.
Compare VersaViewer
VS
Butterfly iQ/iQ+ Ultrasound System vs VersaViewer
Butterfly iQ/iQ+ is a handheld ultrasound system that captures diagnostic images and offers AI-powered tools for real-time guidance and measurements. In contrast, VersaViewer is a software application designed…
VS
Butterfly iQ3 Ultrasound System vs VersaViewer
The Butterfly iQ3 is a handheld, point-of-care ultrasound system with integrated AI for image acquisition and basic analysis, ideal for immediate diagnostic confidence at the bedside. VersaViewer, in…
VS
Brainomix 360 e-CTA vs VersaViewer
Brainomix 360 e-CTA is a specialized AI tool for acute stroke patients, focusing on automated collateral assessment and large vessel occlusion detection on CT angiography scans. VersaViewer, while…
VS
Avenda Health AI Prostate Cancer Planning Software vs VersaViewer
Avenda Health AI Prostate Cancer Planning Software is a specialized AI tool for prostate cancer treatment planning, generating 3D cancer maps from various patient data to aid in…
Suggest an Edit →
| Last Verified: 2026-04-18 | First Added: 2026-04-18